康诺思腾完成约2亿美元C+轮融资

Core Insights - Shenzhen Kangnuo Saiteng Technology Co., Ltd., a high-end surgical robot company, has completed a C+ round financing of approximately $200 million [1] - The financing round was led by Hong Kong Investment Company, Qiming Venture Partners, Daohe Investment, Gao Rong Capital, and Xianfeng K2VC [1] - Established in 2019, the company focuses on the development, manufacturing, and sales of high-end surgical robots, and has built a comprehensive underlying technology platform for surgical robots [1] Company Overview - Kangnuo Saiteng has a production facility of over 10,000 square meters located in the Greater Bay Area [1] - The company's self-developed Sentire laparoscopic surgical robot has received NMPA approval for market launch and is actively pursuing global medical device certifications [1] - Previous funding rounds include investments from EQT in the C round and participation from Qiming Venture Partners in both the B and B+ rounds [1]